Ponce Finl Gr 株価情報 (NASDAQ: PDLB)

最新ニュース Ponce Finl Gr (NASDAQ:PDLB) 株価情報

Ponce Finl Gr

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

Ponce Financial Group, Inc. - Common Stock

Ponce Financial Group Inc

News

IBRX

ImmunityBio Requests Receives Refusal to File Letter From FDA For sBLA For ANKTIVA Plus Bacillus Calmette-Guerin; Co. Requests FDA Meeting To Address Change In Agency's Guidance On Jan. 25

Zimmer Biomet Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZBH#NYSE">ZBH</a>) lowers FY2025 Adj EPS guidance from $8.15-$8.35 to $7.90-$8.10 vs $8.19 analyst estimate. Raises FY2025 sales outlook from $7.76 billion-$7.95 billion to $8.12 billion-$8.31 billion vs $7.91 billion estimate.

Guidance

Zimmer Biomet Holdings Lowers FY2025 Adj EPS Guidance from $8.15-$8.35 to $7.90-$8.10 vs $8.19 Est; Revenue for 2025 FY is expected to up by 5.7% - 8.2% YoY

Needham analyst Mike Cikos reiterates N-able (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NABL#NYSE">NABL</a>) with a Buy and maintains $10 price target.

Price Target

Reiteration

Analyst Ratings

NABL

Needham Reiterates Buy on N-able, Maintains $10 Price Target

Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $0.10 by 360 percent. This is a 170.27 percent decrease over earnings of $0.37 per share from the same period last year. The company reported quarterly sales of $263.25 million which beat the analyst consensus estimate of $260.12 million by 1.20 percent. This is a 17.60 percent increase over sales of $223.85 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

FRPT

Freshpet Q1 EPS $(0.26) Misses $0.10 Estimate, Sales $263.25M Beat $260.12M Estimate

Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) lowers FY2025 sales outlook from $1.18 billion-$1.21 billion to $1.12 billion-$1.15 billion vs $1.18 billion estimate.

Freshpet Lowers FY2025 Sales Guidance from $1.18B-$1.21B to $1.12B-$1.15B vs $1.18B Est

Zimmer Biomet Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZBH#NYSE">ZBH</a>) reported quarterly earnings of $1.81 per share which beat the analyst consensus estimate of $1.77 by 2.26 percent. This is a 6.7 percent decrease over earnings of $1.94 per share from the same period last year. The company reported quarterly sales of $1.91 billion which beat the analyst consensus estimate of $1.90 billion by 0.72 percent. This is a 1.06 percent increase over sales of $1.89 billion the same period last year.

Zimmer Biomet Holdings Q1 Adj. EPS $1.81 Beats $1.77 Estimate, Sales $1.91B Beat $1.90B Estimate

Collective Mining Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNL#NYSE">CNL</a>) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CNL#TSX">CNL</a>) ("Collective" or the "Company") is pleased to announce that drilling assay results at the San Antonio Project's Pound target ("Pound") has resulted in the discovery of a mineralized Au-Ag-Cu-Mo porphyry system. Additionally, the final assay results from the 2024 drill program at the Trap target (Guayabales Project) are reported below. Both the San Antonio and Guayabales projects are situated near to each other and to the famous multi-million-ounce Marmato Mine within the Caldas Department in Colombia.
The Company currently has nine drill rigs operating as part of its fully funded 70,000-metre drill program for 2025 with two rigs at the San Antonio Project and seven rigs at the Guayabales Project. Two additional deep capacity rigs are being mobilized to the Guayabales Project and will begin testing the high-grade Ramp Zone located at the bottom of the Apollo system in early Q3, 2025.

TSX:CNL

Collective Mining Discovers New Porphyry System at San Antonio Project, Expands Drilling Program

Park Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PK#NYSE">PK</a>) lowers FY2025 FFO guidance from $1.90-$2.20 to $1.79-$2.09 vs $1.97 analyst estimate..

Park Hotels & Resorts Lowers FY2025 FFO Guidance from $1.90-$2.20 to $1.79-$2.09 vs $1.97 Est

Needham analyst Ami Fadia reiterates Praxis Precision Medicine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRAX#NASDAQ">PRAX</a>) with a Buy and maintains $80 price target.

PRAX

Needham Reiterates Buy on Praxis Precision Medicine, Maintains $80 Price Target

Integra Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IART#NASDAQ">IART</a>) lowers FY2025 Adj EPS guidance from $2.41-$2.51 to $2.19-$2.29 vs $2.46 analyst estimate. Affirms FY2025 sales outlook from $1.65 billion-$1.72 billion to $1.65 billion-$1.72 billion vs $1.68 billion estimate.

IART

Integra Lifesciences Lowers FY2025 Adj EPS Guidance from $2.41-$2.51 to $2.19-$2.29 vs $2.46 Est; Affirms FY2025 Sales Guidance of $1.65B-$1.72B vs $1.68B Est

Inertial Labs, a <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4419485-1&amp;h=391754438&amp;u=https%3A%2F%2Fwww.viavisolutions.com%2F&amp;a=VIAVI+Solutions+Inc.">VIAVI Solutions Inc.</a> (VIAVI) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIAV#NASDAQ">VIAV</a>) Company, today introduced the IMU-H100, a micro-electromechanical systems (MEMS) <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4419485-1&amp;h=3518287963&amp;u=https%3A%2F%2Finertiallabs.com%2Fproducts%2Fimu-inertial-measurement-units%2F&amp;a=inertial+measurement+unit+(IMU)">inertial measurement unit (IMU)</a> developed to enhance tactical guidance and navigation capabilities of unmanned aerial vehicles (UAVs), short-range missiles and precision guidance munitions, as well as a variety of commercial applications.
&nbsp;
As unmanned vehicle technology improves and personnel safety becomes a top priority, military and commercial sectors are accelerating adoption –&nbsp;driving strong demand for the IMUs that power their navigation and control systems. An IMU measures angular velocity and linear acceleration using MEMS gyroscopes and accelerometers respectively. They have become essential in a wide range of guidance and navigation, orientation and stabilization applications, particularly for short- and medium-range flight control systems. The IMU is also a component of higher order systems such as inertial navigation systems (INS), attitude and heading reference systems (AHRS) and motion reference units (MRU). Applications include autonomous vehicles for land, sea, aerospace and defense.
The tactical-grade IMU-H100 includes accelerometers and gyroscopes for all three axes and offers a gyro and accel bias of 1 deg/hr and 1 mg respectively. The 5 in3, 160 g IMU also exceeds the performance of equivalent products on the market in terms of data rate, measurement range, stability and repeatability over harsh environmental conditions – including vibration, shock, high acceleration, spinning, temperature and acoustic noise.
In addition to its sophisticated capabilities, the IMU-H100 is designed for ease and speed of integration into customers' operations. It supports the Universal Asynchronous Receiver/Transmitter (UART) and Synchronous Data Link Control (SDLC) used in many legacy systems, making it ideal for retrofitting initiatives. It is also ITAR-free, available with a lead time of weeks rather than months, and is manufactured in the United States.

VIAV

Inertial Labs Introduces IMU-H100 for Military and Commercial Applications, Offering Superior Stability and Integration Ease

Integra Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IART#NASDAQ">IART</a>) is looking for Q2 Adj EPS of $0.40-$0.45 vs $0.57 analyst estimate. sees sales of $390.000 million-$400.000 million vs $417.04 million analyst estimate.

Integra Lifesciences Sees Q2 Adj EPS $0.40-$0.45 vs $0.57 Est; Sees Sales $390.000M-$400.000M vs $417.04M Est

Park Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PK#NYSE">PK</a>) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.42 by 9.52 percent. This is a 11.54 percent decrease over earnings of $0.52 per share from the same period last year. The company reported quarterly sales of $630.00 million which beat the analyst consensus estimate of $610.89 million by 3.13 percent. This is a 1.41 percent decrease over sales of $639.00 million the same period last year.

Park Hotels & Resorts Q1 FFO $0.46 Beats $0.42 Estimate, Sales $630.00M Beat $610.89M Estimate

Biotech

Health Care

Management

General

BNTX

BioNTech Has Appointed Ramón Zapata-Gomez As CFO, Effective July 1, 2025. He Will Join BioNTech From Novartis' Global Biomedical Research Organization, Where He Has Been Serving As CFO Since 2022. Ramón Zapata Will Succeed Jens Holstein, Who, As Previously Planned And Announced, Will Retire At The End Of His Term On June 30

The Trump administration has asked the Supreme Court to allow the Department of Government Efficiency (DOGE) to access sensitive Social Security data, furthering a legal battle over data privacy and executive authority.
What Happened: The emergency appeal comes after a divided federal court ruling that <a href="https://www.benzinga.com/personal-finance/25/04/44697671/trump-administrations-push-to-access-social-security-data-faces-major-setback-as-court-dismisses-appeal">stopped DOGE from accessing personal data</a>, including Americans' medical records and bank details.
"The government cannot eliminate waste and fraud," the administration said in its appeal, "if district courts bar the very agency personnel&#8230; from performing their jobs."
Chief Justice John Roberts is reviewing the case, with a May 12 deadline set for responses. Lower courts criticized the amount of data requested, with one judge calling DOGE's effort a "fishing expedition," according <a href="https://edition.cnn.com/2025/05/02/politics/doge-fight-social-security-data-supreme-court">to</a> CNN.
See Also: <a href="https://www.benzinga.com/markets/25/05/45187434/trump-open-to-extending-tiktok-deadline-says-he-has-warm-spot-for-the-app">Trump Open To Extending TikTok Deadline, Says He Has &#8216;Warm Spot&#8217; For The App</a>
Why It Matters: The case will demonstrate how far the executive branch can go in using personal data to update government systems. "District court control of decisions about internal access&#8230; constitutes inappropriate superintendence of a coequal branch," the administration said.
Earlier this month, reports emerged that two individuals linked to DOGE were provided accounts on classified U.S. government networks that manage sensitive nuclear weapons data.
DOGE has been previously linked with privacy and security concerns across other federal agencies, such as its attempts to access <a href="https://www.benzinga.com/news/25/02/43768756/privacy-concerns-emerge-as-elon-musks-doge-team-seeks-access-to-taxpayer-data" target="_blank" rel="noreferrer noopener">taxpayer data</a>, and its reported <a href="https://www.benzinga.com/politics/25/04/44683851/elon-musks-secretive-doge-team-using-ai-and-disappearing-messages-to-monitor-federal-workers-for-anti-trump-sentiment-bypassing-records-laws-and-locking-out-agencies-report" target="_blank" rel="noreferrer noopener">tracking of employee communications using artificial intelligence tools.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45187462/trump-denies-personal-profit-from-memecoin-venture-i-havent-even-looked">Trump Denies Personal Profit From Memecoin Venture: &#8216;I Haven&#8217;t Even Looked&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Politics

Trump Administration Pushes Supreme Court To Greenlight DOGE Access To Social Security Data Despite Lower Court's 'Fishing Expedition' Warning

Integra Lifesciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IART#NASDAQ">IART</a>) reported quarterly earnings of $0.41 per share which missed the analyst consensus estimate of $0.43 by 4.65 percent. This is a 25.45 percent decrease over earnings of $0.55 per share from the same period last year. The company reported quarterly sales of $382.65 million which beat the analyst consensus estimate of $381.17 million by 0.39 percent. This is a 3.74 percent increase over sales of $368.87 million the same period last year.

Integra Lifesciences Q1 Adj. EPS $0.41 Misses $0.43 Estimate, Sales $382.65M Beat $381.17M Estimate

Elanco Animal Health Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELAN#NYSE">ELAN</a>) today announced the sale of certain future tiered royalties and commercial milestones associated with XDEMVY&#xAE; (lotilaner ophthalmic solution) 0.25%, for the human health application of lotilaner, to funds affiliated with Blackstone Life Sciences and Blackstone Credit &amp; Insurance for $295 million in cash. Monetization of this non-core asset will be used to accelerate debt reduction, positioning Elanco to achieve an expected net leverage ratio of 3.9x to 4.3x adjusted EBITDA by the end of 2025. Elanco will repay portions of its outstanding term loans on a pro-rata basis, which is expected to reduce interest expense by approximately $10 million, offset by the sale of approximately $10 million of royalties based on Elanco's initial 2025 guidance.
&nbsp;
In 2019, Elanco exclusively licensed lotilaner to Tarsus Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARS#NASDAQ">TARS</a>) for exploration as a solution to several unmet human health needs. In 2023, XDEMVY became the first lotilaner-based product approved for human use and the only FDA-approved medicine for treatment of Demodex blepharitis (DB), a common eyelid disease in humans caused by Demodex mites.

ELAN

TARS

Elanco Monetizes XDEMVY Royalties in $295M Deal to Lower Debt and Reduce Interest Costs

HC Wainwright &amp; Co. analyst Scott Buck maintains Intrusion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) with a Neutral and raises the price target from $1 to $1.5.

INTZ

HC Wainwright & Co. Maintains Neutral on Intrusion, Raises Price Target to $1.5

U.S. stock futures fell on Monday after a nine-day winning streak on the S&amp;P 500 index. Futures of major benchmark indices were lower in premarket.
The S&amp;P 500 index notched a nine-day advance for the first time since November 2004 on Friday.
While aboard Air Force One, Donald Trump confirmed U.S. officials are <a href="https://www.benzinga.com/news/global/25/05/45188171/china-pushes-for-special-envoys-as-direct-deal-with-trump-deemed-risky-plans-fentanyl-concessions-as-negotiating-leverage-report">engaged in trade discussions</a> with Chinese counterparts, though he has no planned meeting with President Xi Jinping this week. 
While the Chinese have proposed the concept of special envoys, the U.S. is reluctant, favoring direct negotiations between Trump and Xi. However, the Chinese view this proposal as "risky and uncertain", <a href="https://www.scmp.com/news/china/diplomacy/article/3308919/us-china-trade-stand-ease-negotiators-must-be-agreed-upon-analysts">reported</a> the South China Morning Post.
Investors will also keep an eye on the Federal Reserve&#8217;s decision on interest rates this week.
Meanwhile, the 10-year Treasury bond yielded 4.31% and the two-year bond was at 3.82%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>&#8216;s projections show markets pricing a 98.2% likelihood of the Federal Reserve keeping the current interest rates unchanged in its May meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>-0.66%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.77%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.89%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.88%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, fell in premarket on Monday. The SPY was down 0.70% to $562.82, while the QQQ declined 0.84% to $484.74, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
Bolstered by strong performances in financial, communication services, and industrial stocks on Friday, U.S. markets finished the week higher for all major averages.
The S&amp;P 500, which recorded its ninth consecutive day of gains, the longest since Nov. 2004, and added 2.9% for the week, saw contrasting movements with health care and consumer staples declining on Friday. The Dow gained 3% and the Nasdaq rose 3.4% for the week.
After the end of the nine-day streak, the S&amp;P 500 index was out of the correction zone, just down 7.5% from its record high of 6,147.43 points, scaled on Feb. 19. Dow Jones was 8.33% lower than its 52-week high of 45,073.63 points and Nasdaq 100 was 9.54% lower than its previous high of 22,222.61 points.
Strong jobs data and rising factory orders buoyed the market. Nonfarm payrolls exceeded forecasts at 177,000, easing tariff-related hiring concerns, while the unemployment rate held steady at 4.2%. Additionally, new orders for U.S.-manufactured goods jumped 4.3% in March to $618.8 billion.
The Dow Jones index jumped 565 points or 1.39% to 41,317.43, whereas the S&amp;P 500 index surged 1.47% to 5,686.67. Nasdaq Composite ended 1.51% higher at 17,977.73, and the small-cap gauge, Russell 2000, also advanced 2.27% to 2,020.74.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>1.51%</td>
<td>17,977.73</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>1.47%</td>
<td>5,686.67</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>1.39%</td>
<td>41,317.43</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2.27%</td>
<td>2,020.74</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
According to Brian Therien, the investment strategist at Edward Jones, the process of completing a U.S.-China trade deal would likely be complex and lengthy. &#8220;Any de-escalation in trade tensions should be positive for the economy and financial markets, in our view,&#8221; he said.
The solid labor market should allow the Fed to remain on hold a while longer, said Therien, as it will help the Fed to gain greater clarity on the impact of tariffs on inflation.
&#8220;Bond markets have pushed back expectations for the next Fed funds rate cut to July, from June, though total rate cuts priced in for this year remain in the 3-4 range,&#8221; he said.
&#8220;Wider earnings growth should drive more balanced market performance across sectors, strengthening the case for portfolio diversification, in our view,&#8221; he said about corporate earnings.
Ryan Detrick from Carson Research highlighted that the S&amp;P 500 has witnessed seven other nine-day winning streaks over the last 40 years.
&#8220;Only once did the economy move into a recession within six months, and that was in 1990 when oil spiked due to Iraq invading Kuwait,&#8221; he highlighted.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Going back 40 years there have been seven other 9-day win streaks for the S&amp;P 500. Only once did the economy move into a recession within six months and that was in 1990 when oil spiked due to Iraq invading Kuwait.
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1919227797169381422?ref_src=twsrc%5Etfw">May 5, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on this week:
<ul>
<li>On Monday, the S&amp;P final U.S. services PMI for April will be out by 9:45 a.m., and ISM services data for April will be released by 10:00 a.m. ET.</li>
<li>On Tuesday, the U.S. trade deficit data for March will be out by 8:30 a.m.</li>
<li>On Wednesday, the FOMC meeting will begin at 2:00 p.m., and Fed Chairman Jerome Powell will deliver the verdict at a press conference at 2:30 p.m. ET.</li>
<li>Consumer credit for March will be out by 3:00 p.m. ET.</li>
<li>On Thursday, initial jobless claims for the week ended May 3 and U.S. productivity data for the first quarter will be released by 8:30 a.m. ET.</li>
<li>March&#8217;s wholesale inventories data will be out by 10:00 a.m. ET.</li>
<li>On Friday, Fed Governor Michael Barr will speak at 5:55 a.m., New York Fed President John Williams will speak at 6:15 a.m., and Fed Governor Adriana Kugler will speak at 6:45 a.m. ET.</li>
<li>Fed Governor Lisa Cook will speak at 6:45 a.m. ET.</li>
<li>Richmond Fed President Tom Barkin speaks at 8:30 a.m., Fed Governor Christopher Waller and New York Fed President John Williams will speak on a panel at 11:30 a.m. ET.</li>
<li>Fed Governor Michelle Bowman, St. Louis Fed President Alberto Musalem, and Fed Cleveland President Beth Hammack will speak on a panel at 7:45 p.m. ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>Tyson Foods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) rose 2.78% in premarket on Monday as it is expected to report earnings before the opening bell. Analysts expect a quarterly earnings of 82 cents per share on revenue of $13.14 billion.</li>
<li>Cummins Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) was 0.5% higher as Wall Street expects it to report earnings of $4.90 per share on revenue of $8.19 billion before the opening bell.</li>
<li>Transcode Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) dropped 21.67% after announcing a 1-for-28 reverse stock split.</li>
<li>Henry Schein Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSIC#NASDAQ">HSIC</a>) fell 1.36% as it is expected to report earnings before the opening bell. Analysts expect a quarterly earnings of $1.11 per share on revenue of $3.23 billion.</li>
<li>Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) declined 0.19% as Wall Street expects it to report earnings of 2 cents per share on revenue of $36.20 billion after the closing bell.</li>
<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFAI#NASDAQ">FFAI</a>) rose 5.98% after it announced an additional significant pre-order for its FX Super One MPV, adding 300 Units in another B2B Agreement.</li>
<li>Bon Natural Life Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BON#NASDAQ">BON</a>) slumped 13.08% after it received a delisting notice as the stock crashed below 10 cents.</li>
<li>Polyrizon Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) jumped 18.81% as trading on a post-split basis began on May 5.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 1.58% to hover around $57.37 per barrel.
Gold Spot US Dollar rose 1.65% to hover around $3,294.46 per ounce. Its last record high stood at $3,305.13 per ounce. The U.S. Dollar Index spot was lower by 0.39% at the 99.6370 level.
Asian markets were mixed on Monday. China&#8217;s CSI 300 and Australia's ASX 200 indices declined. While Hong Kong's Hang Seng, Japan's Nikkei 225, India's S&amp;P BSE Sensex, and South Korea's Kospi index rose. European markets were also mixed in early trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45188341/billionaire-mark-cuban-asks-if-small-businesses-be-ignored-after-trump-redirects-question-on-tariff-relief-for-little-businesses">Billionaire Mark Cuban Asks Should Small Businesses Be &#8216;Ignored&#8217; After Trump Redirects Question On Tariff Relief For &#8216;Little Businesses&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Market Summary

Futures

Economics

Federal Reserve

Pre-Market Outlook

Markets

Trading Ideas

Faraday Future Intelligent Electric Inc. - Class A Common Stock

FFAI

HSIC

PLRZ

RNAZ

US Stocks Likely To Open Lower After S&P 500's 9-Day Streak: 'Any De-Escalation In Trade Tensions Should Be Positive,' Says Expert

HC Wainwright &amp; Co. analyst Amit Dayal reiterates NPK International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NPKI#NYSE">NPKI</a>) with a Buy and maintains $12 price target.

NPKI

HC Wainwright & Co. Reiterates Buy on NPK International, Maintains $12 Price Target

Press Releases

New Entrepreneurs Graduate from Ponce Bank Small Business Boot Camp

Ponce Financial Group, Inc. Reports Second Quarter 2024 Results

Ponce Bank Received $35 Million in Deposits as part of the Banking Development District Program

Ponce Bank Opens Representative Office in Coral Gables, Florida

Ponce Financial Group, Inc. Reports Third Quarter 2024 Results

Ponce Financial Group, Inc. Announces Participation in a Virtual Bank Conference

Ponce Financial Group, Inc. Reports Fourth Quarter 2024 Results

Ponce De Leon Foundation Grant Awarded in the Amount of $610,000 to Nonprofits

Ponce Bank Re-Designs its Westchester Avenue Bank Branch in the Bronx

Ponce Financial Group, Inc. Reports First Quarter 2025 Results

PDLB

BayCom

Bank of Marin

Blue Ridge Bankshares

Bank7

Carter Bankshares

Colony Bankcorp

Civista Bancshares

Community West Bancshare

Citizens & Northern

The First of Long Island Corporation - Common Stock

First of Long Island

Farmers & Merchants Bancorp, Inc. - Common Stock

Farmers & Merchants

First Bancorp

First Bank

FS Bancorp

NorthEast Community Bancorp, Inc. - Common Stock

NorthEast Community

Orange County Bancorp, Inc. - Common Stock

Orange County Bancorp

Pioneer Bancorp

PCB Bancorp

Patriot National Bancorp Inc. - Common Stock

Patriot Ntl Bancorp

RBB Bancorp

Red River Bancshares, Inc. - Common Stock

Red River Bancshares

Southern First Bancshares, Inc. - Common Stock

Southern First Bancshares

Southern States Bancshares, Inc. - Common Stock

Southern States

USCB Financial Holdings, Inc. - Class A Common Stock

Comments

Ponce Finl Gr

ニュース

最新ニュース Ponce Finl Gr (NASDAQ:PDLB) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル